Status:
COMPLETED
Hearing Aid Transmitter Performance Study - SRF-366
Lead Sponsor:
Sonova AG
Conditions:
Hearing Loss
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Sonova Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated ma...
Detailed Description
In this study a comparison with two Phonak Receiver in Canal (RIC) devices is done. The experimental device with a modified hearing aid loudspeaker concept and the active comparator with the existing ...
Eligibility Criteria
Inclusion
- Adult hearing impaired persons (minimum age: 18 years, mild to moderate Hearing loss)
- Good written and spoken English language skills
- Healthy outer ear
- Ability to fill in a questionnaire (p/eCRF) conscientiously
- Willingness to wear Receiver in Canal hearing aids
- Informed Consent as documented by signature
- Normal cognitive abilities
Exclusion
- Contraindications to the MD in this study, e.g. known hypersensitivity or allergy to the investigational product
- Limited mobility and not in the position to attend weekly appointments in Sydney (AUS)
- Limited ability to describe listening impressions/experiences and the use of the hearing aid
- Inability to produce a reliable hearing test result
- Known psychological problems
Key Trial Info
Start Date :
April 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 25 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04774185
Start Date
April 26 2021
End Date
April 25 2022
Last Update
March 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Acoustic Laboratories
Sydney, Australia